Cholera Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Cholera clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 2

Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children

Cholera Vaccination
International Vaccine Institute390 enrolled1 locationNCT07509047
Recruiting
Phase 4

Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya

Cholera Vaccination
Albert B. Sabin Vaccine Institute1,071 enrolled1 locationNCT07487077
Recruiting
Not Applicable

Vaccine- and Infection-derived Correlates of Protection for Cholera.

Cholera
Massachusetts General Hospital1,221 enrolled1 locationNCT06455852
Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Streptococcus PneumoniaeMalariaMeningitis+55 more
Institut Pasteur du Cambodge10,000 enrolled1 locationNCT07358910
Recruiting
Phase 3

Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus

Cholera Vaccination
International Vaccine Institute2,824 enrolled5 locationsNCT07304284
Recruiting
Not Applicable

Preventative Intervention for Cholera for 7 Days

Diarrhea InfectiousCholeraWater-Related Diseases
Johns Hopkins Bloomberg School of Public Health2,900 enrolled2 locationsNCT05166850
Recruiting
Not Applicable

Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)

DiarrheaCholera
Johns Hopkins Bloomberg School of Public Health3,140 enrolled2 locationsNCT06003816
Recruiting
Phase 4

CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera

Typhoid and/or Cholera Vaccination
University of Maryland, Baltimore240 enrolled1 locationNCT03705585
Recruiting
Not Applicable

Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)

Diarrhea InfectiousCholera
Johns Hopkins Bloomberg School of Public Health1,600 enrolled1 locationNCT06498817
Recruiting

Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance

Cholera
Epicentre6,000 enrolled1 locationNCT04853186